Novel Masters of Erythropoiesis: Hypoxia Inducible Factors and Recent Advances in Anemia of Renal Disease

Publisher： Karger

E-ISSN： 1421-9735|42|2|160-167

ISSN： 0253-5068

Source： Blood Purification, Vol.42, Iss.2, 2016-06, pp. : 160-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

By  

American Journal of Nephrology, Vol. 45, Iss. 3, 2017-01 ,pp. : 187-199

Karger

Access to resources Recommend Favorite

Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects

By  

American Journal of Nephrology, Vol. 45, Iss. 2, 2016-12 ,pp. : 127-135

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors but Not Angiotensin II AT 1 Receptor Antagonists Affect Erythropoiesis in Patients with Anemia of End-Stage Renal Disease

By  

Nephron, Vol. 81, Iss. 1, 1999-01 ,pp. : 106-108

Karger

Access to resources Recommend Favorite

Role of Hypoxia in the Pathogenesis of Renal Disease

By  

Blood Purification, Vol. 21, Iss. 3, 2003-06 ,pp. : 253-257

Karger

Access to resources Recommend Favorite

Levocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia

By  

Cardiorenal Medicine, Vol. 7, Iss. 3, 2017-04 ,pp. : 188-197

Karger

Access to resources Recommend Favorite